HXL Insider Trading

Insider Ownership Percentage: 63.83%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Hexima Insider Trading History Chart

This chart shows the insider buying and selling history at Hexima by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hexima Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 03/21/2024 12:12 PM ET

This chart shows the closing price history over time for HXL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Hexima Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/20/2024Geoffrey KemplerInsiderIssued3,350,000A$0.01A$43,550.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Hexima (ASX:HXL)

2.81% of Hexima stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics in Australia. The company's lead drug candidate is the pezadeftide, which has completed phase II clinical trials for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Bundoora, Australia.
Read More on Hexima

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Hexima?

Hexima's top insider shareholders include:
  1. Geoffrey Kempler (Insider)
Learn More about top insider investors at Hexima.